ConductScience.org, home

Paper526002

Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.

Wallace RJ and 2 others. Antimicrob Agents Chemother, 1979. Cited by 109 papers, by iCite.

Cite this record

ConductScience Library. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Papers, record 526002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/526002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
109
iCite
Relative citation ratio, by iCite
5
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wallace RJ JrR J
2Dalovisio JRJ R
3Pankey GAG A

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
MycobacteriumMajor topic
Aminoglycosides
Culture Media
Erythromycin
Microbial Sensitivity Tests
Tetracyclines

Source PubMed

Download CSV of topics

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1475359Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/475359PubMed
2726085Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.Tubercle1978https://conductscience.org/library/papers/726085PubMed
35544146In-vitro activity of erythromycin against atypical mycobacteria.J Infect Dis1971https://conductscience.org/library/papers/5544146PubMed
4900925Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/900925PubMed
54746583Clinical significance of Mycobacterium fortuitum infections in pulmonary disease.Am Rev Respir Dis1973https://conductscience.org/library/papers/4746583PubMed
6632627In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.J Infect Dis1978https://conductscience.org/library/papers/632627PubMed

Download CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.

PMIDTitleJournalYearIn PapersSource
42498785Luteoagmacins A and B, new antimicrobial agmatine derivatives from a hot spring water-derived Luteococcus sp.J Antibiot (Tokyo)2026https://conductscience.org/library/papers/42498785PubMed
41635493Cephalexin-loaded polyvinyl alcohol/graphene oxide thin films as antibacterial wound dressing.RSC Adv2026https://conductscience.org/library/papers/41635493PubMed
39356365
Design, synthesis, and computational analysis (molecular docking, DFT, MEP, RDG, ELF) of diazepine and oxazepine sulfonamides: biological evaluation for in vitro and in vivo anti-inflammatory, antimicrobial, and cytotoxicity predictions.
Mol Divers2025https://conductscience.org/library/papers/39356365PubMed
38024963
A synergistic investigation of azo-thiazole derivatives incorporating thiazole moieties: a comprehensive exploration of their synthesis, characterization, computational insights, solvatochromism, and multimodal biological activity assessment.
RSC Adv2023https://conductscience.org/library/papers/38024963PubMed
37606184Review of methods for detection and characterization of non-tuberculous mycobacteria in aquatic organisms.J Vet Diagn Invest2024https://conductscience.org/library/papers/37606184PubMed
34946162Evolution of Antibacterial Drug Screening Methods: Current Prospects for Mycobacteria.Microorganisms2021https://conductscience.org/library/papers/34946162PubMed
33573039Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models.Biology (Basel)2021https://conductscience.org/library/papers/33573039PubMed
27782812Real time PCR for the rapid identification and drug susceptibility of Mycobacteria present in Bronchial washings.BMC Infect Dis2016https://conductscience.org/library/papers/27782812PubMed
23968779Mycobacterium chelonae abscesses associated with biomesotherapy, Australia, 2008.Emerg Infect Dis2013https://conductscience.org/library/papers/23968779PubMed
22763637Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Clin Microbiol Rev2012https://conductscience.org/library/papers/22763637PubMed
22673307Tetracycline resistance and presence of tetracycline resistance determinants tet(V) and tap in rapidly growing mycobacteria from agricultural soils and clinical isolates.Microbes Environ2012https://conductscience.org/library/papers/22673307PubMed
17088352Characterization of the Mycobacterium tuberculosis sigma factor SigM by assessment of virulence and identification of SigM-dependent genes.Infect Immun2007https://conductscience.org/library/papers/17088352PubMed
11716590Infection of the subcutis and skin of cats with rapidly growing mycobacteria: a review of microbiological and clinical findings.J Feline Med Surg2000https://conductscience.org/library/papers/11716590PubMed
10325306Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.J Clin Microbiol1999https://conductscience.org/library/papers/10325306PubMed
8793407Mycobacterium fortuitum bacteremia in an immunocompromised patient with a long-term venous catheter.Eur J Clin Microbiol Infect Dis1996https://conductscience.org/library/papers/8793407PubMed
8253968DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus.J Clin Microbiol1993https://conductscience.org/library/papers/8253968PubMed
7989530Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.J Clin Microbiol1994https://conductscience.org/library/papers/7989530PubMed
7665643Evaluation of Etest for susceptibility testing of rapidly growing mycobacteria.J Clin Microbiol1995https://conductscience.org/library/papers/7665643PubMed
7325629Susceptibility of Mycobacterium marinum to tetracyclines and aminoglycosides.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7325629PubMed
7247358In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7247358PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/526002

GET https://conductscience.org/api/papers/v1/526002/cited_by?page=2